Proteases
-
Velpatasvir
Catalog No. A17302 HCV NS5A inhibitorVelpatasvir, also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. 了解更多 -
Ombitasvir (ABT-267)
Catalog No. A17624 HCV NS5A inhibitorOmbitasvir is a potent inhibitor of the hepatitis C virus protein NS5A, with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype 6a. 了解更多 -
Paritaprevir (ABT-450)
Catalog No. A17625 HCV NS3/4A inhibitorParitaprevir (ABT-450) is a potent non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. 了解更多 -
Ledipasvir acetone
Catalog No. A18055 HCV NS5A inhibitorLedipasvir acetone is the active pharmaceutical ingredient of Ledipasvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. 了解更多 -
Voxilaprevir
Catalog No. A12067 HCV NS 3/4A protease inhibitorVoxilaprevir (GS-9857) is a fluorinated macrocyclic hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor with potent in vitro antiviral activity against genotypes 1-6 HCV and broad coverage of NS3/4A protease polymorphisms. GS-9857 improves coverage against commonly encountered NS3 resistance-associated variants (RAVs). 了解更多 -
Mericitabine
Catalog No. A11539 HCV NS5B polymerase inhibitorMericitabine (RG 7128; R-7128) is a nucleoside inhibitor of the HCV NS5B polymerase that acts as an RNA chain terminator and prevents elongation of RNA transcripts during replication. 了解更多 -
PSI-352938
Catalog No. A21253 HCV nucleotide inhibitorPSI-352938 (PSI-938) is a hepatitis C virus (HCV) nucleotide inhibitor. 了解更多 -
Beclabuvir
Catalog No. A21511 HCV NS5B RNA-dependent RNA polymerase inhibitorBeclabuvir is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, and inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 with IC50 of < 28 nM. 了解更多 -
Sofosbuvir impurity C
Catalog No. A21636 HCV RNA replication inhibitorSofosbuvir impurity C is the less active impurity of Sofosbuvir, Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. 了解更多 -
Sofosbuvir impurity A
Catalog No. A21641 HCV RNA replication inhibitorSofosbuvir impurity A, an diastereoisomer of sofosbuvir, is the impurity of sofosbuvir. Sofosbuvir (PSI-7977) is an inhibitor of HCV RNA replication, demonstrates potent anti-hepatitis C virus activity. 了解更多 -
PSI-6206 13CD3
Catalog No. A21782 HCV NS5B polymerase inhibitorPSI-6206 13CD3 is the deuterium labeled PSI-6206. PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. 了解更多 -
MLN9708
Catalog No. A10602 -
Bortezomib (Velcade)
Catalog No. A10160 Proteasome 抑制剂Bortezomib (Velcade)是26S蛋白酶体的高度选择性,可逆抑制剂。 了解更多 -
MLN2238 (Ixazomib)
Catalog No. A10600 Proteasome 抑制剂MLN2238 (Ixazomib)是20S蛋白酶体抑制剂的有效可逆特异性β5位点,IC50值为3.4 nM。 了解更多 -
CEP-18770 (Delanzomib)
Catalog No. A11145 Proteasome 抑制剂CEP-18770 (Delanzomib)是一种新型口服活性蛋白酶体抑制剂,IC50为3.8 nM,具有良好的肿瘤选择性,可用于治疗对蛋白酶体抑制有反应的MM和其他恶性肿瘤。 了解更多 -
PR-171 (Carfilzomib)
Catalog No. A11278 Proteasome 抑制剂PR-171 (Carfilzomib)是四肽环氧酮和选择性蛋白酶体抑制剂。它是环氧霉素的类似物。 了解更多 -
Lactacystin
Catalog No. A12768 -
Gliotoxin
Catalog No. A13711 -
ONX 0912 (Oprozomib)
Catalog No. A14181 Proteasome 抑制剂ONX 0912 (Oprozomib)是一种三肽环氧酮,可抑制对常规和硼替佐米治疗耐药的MM细胞的生长并诱导其凋亡。 了解更多 -
PI-1840
Catalog No. A14146 -
Marizomib (NPI-0052, salinosporamide A)
Catalog No. A13853 Proteasome 抑制剂Marizomib (NPI-0052,salinosporamide A)是一种天然存在的salinosporamide,从海洋放线菌Salinospora tropica中分离出来,具有潜在的抗肿瘤活性。 了解更多 -
Aclacinomycin A
Catalog No. A14910 -
Dihydroeponemycin
Catalog No. A14932 -
Clasto-Lactacystin b-lactone
Catalog No. A15427 20S proteasome 抑制剂Clasto-Lactacystin b-lactone被鉴定为乳酸的活性代谢产物,这是由于半胱氨酸的消除和反应性b-内酯的形成所致。 了解更多 -
MG-262
Catalog No. A12220 -
Epoxomicin
Catalog No. A12730 -
Proteasome-IN-1
Catalog No. A12254 proteasome inhibitorProteasome-IN-1 is a proteasome inhibitor extracted from patent WO 2013142376 A1. 了解更多 -
Ixazomib citrate
Catalog No. A18017 20S proteasome inhibitorIxazomib citrate (MLN9708) is a reversible inhibitor of the chymotrypsin-like proteolytic β5 site of the 20S proteasome with an IC50 of 3.4 nM and a Ki of 0.93 nM. 了解更多 -
(R)-MG-132
Catalog No. A21980 proteasome inhibitor(R)-MG-132 ((S,R,S)-(-)-MG-132) is the enantiomer of MG-132. (R)-MG-132 is a proteasome inhibitor with weaker cell cytotoxicity than MG-132. (R)-MG-132 stereoisomer is a more potent proteasome inhibitor than MG-132. 了解更多 -
BMS-708163 (Avagacestat)
Catalog No. A10157 Gamma-secretase 抑制剂BMS-708163 (Avagacestat)是口服生物有效的,选择性的γ-分泌酶抑制剂,作用于Aβ40和Aβ42时,IC50分别为0.3 nM和0.27 nM。 了解更多 -
DAPT (GSI-IX)
Catalog No. A10288 Gamma secretase 抑制剂DAPT (GSI-IX)是一种γ-分泌酶抑制剂,可导致人原代神经元培养物中Aβ40和Aβ42水平降低,总Aβ和Aβ42的IC50值分别为115和200 nM。 了解更多 -
Semagacestat (LY450139)
Catalog No. A10836 Gamma-secretase 抑制剂Semagacestat (LY450139)是一种针对Aβ42,Aβ40和Aβ38的γ-分泌酶阻滞剂,IC50分别为10.9 nM,12.1 nM和12.0 nM。 Semagacestat还抑制Notch信号传导,IC50为14.1 nM。 了解更多 -
LY2811376
Catalog No. A11776 -
BMS 433796
Catalog No. A11337